USPTO serial 79336071
H
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 31, 2023
- Examiner
- FENNESSY, EDWARD JOHN
- Law office
- TMEG LAW OFFICE 101
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with H?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nazly Aileen Bayramoglu
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road Suite 100Henderson, NV 89014UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Protein in raw material form for scientific and medical research; enzyme preparations for industrial purposes; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; Biological preparations for use in industry and science; Biological preparations for use in science; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical test paper; plant growth regulating preparations | ACTIVE | — |
| 005 | Chemical preparations for the diagnosis of pregnancy; Antibiotics for human use; Vaccines for human use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; medicinal drinks; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; pharmaceutical preparations, namely, antibody drugs for the treatment of cancer, tumors, anti-rejection of organ transplantation; pharmaceutical preparations for the treatment of tumors, cancer and infectious diseases, namely, antibodies, antibody derivatives, antibody-drug conjugates for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic preparations, protein dietary supplements; diagnostic preparations for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; antiseptic | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; apparatus for artificial respiration; diagnostic apparatus for medical purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; breath gas analyzers for medical diagnostics; medical diagnostic instruments for the analysis of body fluids; medical instruments for analysing and identifying bacteria; dental apparatus, electric; galvanic therapeutic appliances; beds specially made for medical purposes; feeding bottles; orthopedic articles, namely, orthopedic braces; suture materials | ACTIVE | — |
| 042 | Technological research in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies, namely, conducting scientific project feasibility studies; conducting technical project studies in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies in the field of custom design and development of chemical reagents and biochemical assays; research and development of new products for others; scientific laboratory services; cosmetic research; chemical analysis; chemistry services, namely, consultation in the field of chemistry, research and development services in the field of immunocytochemistry, chemical and biomolecular analysis, research in the fields of chemistry and biochemistry, chemical research laboratory services, consultancy in the field of biochemistry, research and development services in the field of biochemistry; chemical research; biological research; bacteriological research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WUHAN HUAMEI BIOTECH CO., LTD.
- Other trademarks owned by WUHAN HUAMEI BIOTECH CO., LTD.
- Other trademarks owned by WUHAN HUAMEI BIOTECH CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named H
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 26, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 2, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 2, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 31, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 11, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 23, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 23, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 15, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 26, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 26, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 6, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 29, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 8, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 8, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 27, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |